We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Science Group Plc | LSE:SAG | London | Ordinary Share | GB00B39GTJ17 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 415.00 | 410.00 | 420.00 | 415.00 | 415.00 | 415.00 | 1,076 | 07:44:24 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Business Consulting Svcs,nec | 98.82M | 10.56M | 0.2322 | 17.87 | 188.65M |
TIDMSAG
RNS Number : 4334F
Science Group PLC
16 November 2020
The following amendment has been made to the 'Transaction in Own Shares' announcement released on 13 November 2020 under RNS No 1910F.
The date of the purchase of the shares has been corrected from 12 October 2020 to 12 November 2020 . All other details remain unchanged. The full amended text is shown below.
13 November 2020
Science Group plc
(the "Company" or "Science Group")
Transaction in own shares
Science Group plc (AIM:SAG) announces that, on 12 November 2020, it purchased 50,000 of its 1 pence ordinary shares at an average price of 235.0 pence per share. The highest price paid per share was 235.0 pence and the lowest price paid per share was 235.0 pence. The Company purchased these shares through Liberum Capital Limited.
The number of shares purchased represented 0.06% of the voting rights attributable to the total ordinary shares in issue prior to the purchase. The purchased shares will be held in treasury.
The total number of ordinary shares in issue (excluding treasury shares) following this announcement is 41,821,812. Science Group holds 240,223 shares in treasury. The total number of voting rights in the Company following this announcement is 41,717,412.
The figure of 41,717,412 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the FCA's Disclosure and Transparency Rules.
Schedule of Purchases - Individual Transactions
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the schedule below contains detailed information about the purchases made by Liberum Capital Limited on behalf of the Company.
Number of shares purchased Transaction price (per share) Time of transaction Execution venue 50000 235.0 13:44:59 AIMX - Ends - For further information: Science Group plc Sarah Cole, Company Secretary Tel: +44 (0) 1223 875 200 www.sciencegroup.com Stifel Nicolaus Europe Limited (Nominated Adviser and Joint Broker) Nick Adams, Alex Price Tel: +44 (0) 20 7710 7600 Liberum Capital Limited (Joint Broker) Neil Patel, Cameron Duncan Tel: +44 (0) 20 3100 2000
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
POSKKABNKBDDPDD
(END) Dow Jones Newswires
November 16, 2020 05:45 ET (10:45 GMT)
1 Year Science Chart |
1 Month Science Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions